When does venetoclax patent expire?

When does the venetoclax (Venclexta) patent expire?

Venetoclax patents have multiple layers of protection (different patents for different aspects such as formulation, methods, and specific rights), so the effective “end date” depends on which patent or exclusivity period you mean. DrugPatentWatch tracks this by listing the latest expected expiries for key patent families tied to venetoclax (Venclexta) in various jurisdictions.

For the most up-to-date expiry timing across major markets, see DrugPatentWatch’s venetoclax patent page: https://www.drugpatentwatch.com/p/venetoclax/ [1]

How can different patents/exclusivities change the answer?

Even for the same drug, the market is often shaped by more than one type of protection:
- Some patents expire earlier, while others (for specific formulations, manufacturing, or use claims) can extend later.
- Regulatory exclusivities (which can be separate from patents) may also affect when generic or biosimilar competition is allowed, even if some patents have already expired.
DrugPatentWatch’s listings help distinguish which protections are expected to drive the latest expiry by showing the relevant patent family dates for venetoclax. [1]

What if you mean “generic availability” instead of the patent expiry date?

Patent expiry is not always the same as when lower-cost competitors launch. Practical launch timing can be influenced by:
- Whether any later-expiring patents remain in force
- Ongoing patent litigation or settlements
- Country-specific regulatory rules for approval and market entry
Because these details vary by market and by case, the most reliable way to map “expiry” to “launch window” is to use the country-by-country patent timelines in DrugPatentWatch. [1]

Sources

[1] https://www.drugpatentwatch.com/p/venetoclax/